Skip to main content
. 2019 May;16(2):350–360. doi: 10.20892/j.issn.2095-3941.2018.0378

2.

The details of recurrence and metastasis between the two groups

CIK group (n = 16) Control group (n = 29) P
Sites 0.581
 Chest wall 3/16 (18.8%) 6/29 (20.7%)
 Regional lymph node 4/16 (25.0%) 5/29 (17.2%)
 Lung 6/16 (37.5%) 12/29 (41.4%)
 Bone 6/16 (37.5%) 9/29 (31.0%)
 Liver 3/16 (18.8%) 5/29 (17.2%)
 Brain 3/16 (18.8%) 4/29 (13.8%)
 Other sites 1/16 (6.3%) 2/29 (6.9%)
Numbers of metastatic sites 0.628
 1 7/16 (43.7%) 14/29 (48.3%)
 2 1/16 (6.3%) 4/29 (13.8%)
 ≥ 3 8/16 (50.0%) 11/29 (37.9%)